Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.

Cancer prevention research (Philadelphia, Pa.) - 1 Aug 2008

Gazdar Adi F, Minna John D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autocrine Communication
Share to Carcinoma, Non-Small-Cell Lung
Share to Disease Progression
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, erbB-1

Share to Lung Neoplasms

Share to Models, Biological

Source

Open in PubMed Open full text

Identifiers

PMID: 19138950
DOI: 10.1158/1940-6207.CAPR-08-0080
PMCID: PMC2849648

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.PMID 19138950Read ↗

EGFR gene deregulation mechanisms in lung adenocarcinoma: A molecular reviewSemantic proximity Read ↗

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities.Semantic proximity Read ↗

Oncogenic alterations in advanced NSCLC: a molecular super-highwaySemantic proximity Read ↗

Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics.Semantic proximity Read ↗

Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond.Semantic proximity Read ↗

EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.Semantic proximity Read ↗

Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations.Semantic proximity Read ↗

Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Oncogenic driver mutations in lung cancerSemantic proximity Read ↗

Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A ReviewSemantic proximity Read ↗

EGFR signaling pathway as therapeutic target in human cancers.Semantic proximity Read ↗

EGFR mutations and the terminal respiratory unit.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.